• Build a presence in both the US and European markets for a Series B-funded biotech company with breakthrough biological med-tech products advancing the standard of care in bone and tissue regenerative medicine
  • Create understanding and acceptance of its 3-dimensional, extracellular matrix (ECM) using adipose-derived stem cells (ASCs), to generate growth factors and miRNAs to restore the physiology of natural healing
  • Nuture investor interest and commitment as well as media visibility for a Series-C fundraising leading to a US public listing

Collage of articles related to work done with Novadip

LHS Solutions

  • LHS Immersion® presentation and materials – Blueprint plan with media recommendations and investor targets, 30/60/90-day plans, messaging, corporate timeline, story lines outreach tactics for leading up to an eventual Series C financing
  • Developed a compelling, differentiated message platform that articulates Novadip Biosciences’ value proposition
  • Informed the development of a Blueprint Plan that delivered Novadip Biosciences’ value narrative and key messages to target audiences


  • Spearheaded content development for Novadip’s website – intuitive site navigation, extensive visual illustrations and a modern and dynamic design enhancing the Company’s brand and identity and credibility in the US market
  • Developed and managed the launch of a comprehensive media strategy, social media plan, and corporate/investor presentation for the Company
  • Implemented communications plans including ongoing media and thought leadership placements in industry and scientific publications
  • Increased appreciation, enthusiasm and understanding of Novadip Biosciences’ technology and value proposition among potential investors, investment bankers, industry analysts and potential business partners
  • All Case Studies